國家級人體生物資料庫整合平台共同資料模式實作指引(NBCT Common Data Model IG)
0.1.0 - trial-use
This page is part of the 國家級人體生物資料庫整合平台共同資料模式實作指引(NBCT Common Data Model IG) (v0.1.0: Releases) based on FHIR (HL7® FHIR® Standard) R4. This is the current published version in its permanent home (it will always be available at this URL). For a full list of available versions, see the Directory of published versions
Official URL: https://www.ghd.tw/cdm-fhir/fhir/ValueSet/CRLF-PNI | Version: 0.1.0 | |||
Active as of 2024-09-01 | Computable Name: CRLFPNIValueSet |
CRLF神經侵襲值集
References
Generated Narrative: ValueSet CRLF-PNI
https://www.ghd.tw/cdm-fhir/fhir/CodeSystem/CRLF-PNI
Generated Narrative: ValueSet
Expansion based on codesystem 神經侵襲代碼系統 v0.1.0 (CodeSystem)
This value set contains 5 concepts
Code | System | Display |
0 | https://www.ghd.tw/cdm-fhir/fhir/CodeSystem/CRLF-PNI | 無神經侵襲 |
1 | https://www.ghd.tw/cdm-fhir/fhir/CodeSystem/CRLF-PNI | 有神經侵襲 |
7 | https://www.ghd.tw/cdm-fhir/fhir/CodeSystem/CRLF-PNI | (1)病理報告描述為 NA 或無法評估 (2)病理樣本非常小,無法判斷 (3)病理報告提及樣本不足以判斷是否有神經侵襲 (4)所有原發部位病理報告皆未描述神經侵襲情形 (5)原發部位有執行病理檢查,但病理報告描述無惡性細胞 |
8 | https://www.ghd.tw/cdm-fhir/fhir/CodeSystem/CRLF-PNI | 不適用:(1)GIST、NETs、High grade dysplasia (Severe dysplasia)、原位癌 (2)淋巴瘤及白血病 (3)Plasma cell myeloma (4)中樞神經系統之惡性腫瘤 (5)原發部位不詳 (6)原發部位未執行病理檢查或僅執行細胞學檢查 |
9 | https://www.ghd.tw/cdm-fhir/fhir/CodeSystem/CRLF-PNI | 病歷未記載或不詳 |
Explanation of the columns that may appear on this page:
Level | A few code lists that FHIR defines are hierarchical - each code is assigned a level. In this scheme, some codes are under other codes, and imply that the code they are under also applies |
System | The source of the definition of the code (when the value set draws in codes defined elsewhere) |
Code | The code (used as the code in the resource instance) |
Display | The display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application |
Definition | An explanation of the meaning of the concept |
Comments | Additional notes about how to use the code |